Brain neoplasm
Therapeutic area
Neurology
Rare disease
No
- Definition
- A neoplasm (disease) that involves the brain.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Brain neoplasm
- Therapeutic area
- Neurology
- brain neoplasm
- brain neoplasm (disease)
- brain neoplasms
- brain tumor
- brain tumour
- neoplasm of brain
- neoplasm of the brain
- tumor of brain
- tumor of the Brain
- tumour of brain
- tumour of the Brain
- Severity
- Severe
- Neurology
- Oncology
- MONDO ID
- MONDO:0021211
- Parent condition
- MONDO:0005560
Related records
Broader conditions (12)
- Brain disorder
- Cancer or benign tumor
- Central nervous system disorder
- Central nervous system neoplasm
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Nervous system disorder
- Nervous system neoplasm
Narrower conditions (214)
- ACTH-producing pituitary gland adenoma
- ACTH-producing pituitary gland carcinoma
- ACTH-producing pituitary gland neoplasm
- Adult brain ependymoma
- Adult brain stem neoplasm
- Adult brainstem astrocytoma
- Adult brainstem glioma
- Adult brainstem gliosarcoma
- Adult brainstem mixed glioma
- Adult cerebellar neoplasm
- Adult choroid plexus neoplasm
- Adult medulloblastoma
- Adult pineal parenchymal tumor
- Adult pineoblastoma
- Anaplastic/large cell medulloblastoma
- Anterior optic tract meningioma
- Atypical choroid plexus papilloma
- Benign choroid plexus neoplasm
- Benign neoplasm of brain
- Benign neoplasm of brain stem
Trials (2,351)
- (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
- (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
- [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
- [18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis
- [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
- [18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
- [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
- [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
- [F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
- 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
- 11C Topotecan PET Imaging
- 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
- 18-F-Fluoroacetate as PET Imaging Agent
- 18F ML-10 for Early Detection of Response of Brain Metastases to SRS
- 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT
- 18F-DOPA II - PET Imaging Optimization
- 18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions
- 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
- 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Approved drugs (3)
- Lomustine
- Methylprednisolone acetate
- Prednisone
Drugs in development (127)
- Abemaciclib Phase 2
- ABT-510 Phase 1
- Aflibercept Phase 2
- Alectinib Phase 2
- Aminolevulinic acid Phase 2
- Aminolevulinic acid hydrochloride Phase 1
- Amoxicillin Phase 1
- ANG1005 Phase 2
- Antineoplaston A10 Phase 2
- Azacitidine Early phase 1
- Bevacizumab Phase 3
- Binimetinib Phase 1
- Brivaracetam Early phase 1
- Bupivacaine Phase 1
- Busulfan Phase 1
- Capecitabine Phase 2
- Carboplatin Phase 3
- Carmustine Phase 2
- Cediranib Phase 1
- Cediranib maleate Phase 2
Other linked drugs (5)
- Ergocalciferol
- Fluorescein
- Fluorodopa F 18
- Norepinephrine
- Sulfasalazine